Home > Nanotechnology Columns > Bergeson & Campbell, P.C. > NIA Will Hold Webinar on Nanomedicine: Diagnostics and Therapeutics Advancing through Nanotechnology
Lynn L. Bergeson Managing Director Bergeson & Campbell, P.C. |
Abstract:
On March 7, 2018, the Nanotechnology Industries Association (NIA) will hold a webinar on ¡§Nanomedicine: Diagnostics and therapeutics advancing through nanotechnology.¡¨
February 8th, 2018
NIA Will Hold Webinar on Nanomedicine: Diagnostics and Therapeutics Advancing through Nanotechnology
On March 7, 2018, the Nanotechnology Industries Association (NIA) will hold a webinar on ¡§Nanomedicine: Diagnostics and therapeutics advancing through nanotechnology.¡¨ See http://nanotechia.org/events/nanomedicine-diagnostics-and-therapeutics-advancing-through-nanotechnology The webinar will focus on the diagnostic and therapeutic applications of nanotechnology, with the agenda including:
- Regulatory landscape in Europe and beyond for nanomaterials in healthcare applications; and
- Industry developments within nanomedicine from NIA Members:
„«-- Endomag -- A United Kingdom/U.S. small- or medium-sized enterprise (SME) with minimally-invasive surgical guidance platform using magnetism (magnetized nanoparticles) to improve tissue localization in surgical oncology; and
„«-- Senolytx -- A Spanish/U.S. SME developing a nanoparticle-based theraorutic composed of a mesoporous silica scaffold, loaded with the cyctotoxic doxorubin.
The webinar is open to all interested applicants and presentations will be available to all attendees. Registration is now open. See http://nanotechia.org/webform/nanomedicine-diagnostics-and-therapeutics-advancing-through-nanotechnology-registration.
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||